Home / Publication / Population Pharmacokinetics of Bevacizumab in Cancer Patients with External Validation

論文

Population Pharmacokinetics of Bevacizumab in Cancer Patients with External Validation

Population Pharmacokinetics of Bevacizumab in Cancer Patients with External Validation

Author(s): Kelong Han, Thomas Peyret, Mathilde Marchand, Angelica Quartino, Nathalie Gosselin, Sandhya Girish, David Allison, Jin Jin

Year: 2016年8月1日

関連コンテンツ

How Model-informed drug development rescue projects from a risky situation

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

ウェビナー

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

ウェビナー

© 2025 Certara. All Rights Reserved. | 個人情報保護

Powered by Translations.com GlobalLink Web Software